Cannabis Global, Inc. (CBGL)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Cannabis Global Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| August 31, 2025 | -0.8033 |
| May 31, 2025 | -0.834 |
| February 28, 2025 | -0.834 |
| November 30, 2024 | -0.8463 |
| August 31, 2024 | -0.8359 |
| May 31, 2024 | -0.8475 |
| February 29, 2024 | -0.8559 |
| November 30, 2023 | -0.8679 |
| August 31, 2023 | -0.8823 |
| May 31, 2023 | -0.9102 |
| February 28, 2023 | -0.9212 |
| November 30, 2022 | -0.8523 |
| August 31, 2022 | -0.9646 |
| May 31, 2022 | 1.337 |
| February 28, 2022 | 1.255 |
| November 30, 2021 | 7.258 |
| August 31, 2021 | 1.880 |
| May 31, 2021 | -11.59 |
| February 28, 2021 | 12.20 |
| November 30, 2020 | -2.835 |
| May 31, 2020 | -0.3485 |
| February 29, 2020 | -1.021 |
| November 30, 2019 | -1.053 |
| August 31, 2019 | 0.7704 |
| May 31, 2019 | -0.7665 |
| Date | Value |
|---|---|
| February 28, 2019 | -0.6761 |
| November 30, 2018 | -0.7089 |
| August 31, 2018 | -0.6859 |
| May 31, 2018 | -0.661 |
| February 28, 2018 | -0.6164 |
| November 30, 2017 | -0.6539 |
| August 31, 2017 | -0.7856 |
| May 31, 2017 | -0.8055 |
| February 28, 2017 | -0.8264 |
| November 30, 2016 | -0.8475 |
| August 31, 2016 | -0.8685 |
| May 31, 2016 | -0.8917 |
| February 29, 2016 | -0.9174 |
| November 30, 2015 | -0.9409 |
| August 31, 2015 | -0.9615 |
| May 31, 2015 | -1.090 |
| February 28, 2015 | -1.292 |
| November 30, 2014 | -1.671 |
| August 31, 2014 | -2.834 |
| May 31, 2014 | -4.516 |
| February 28, 2014 | -11.11 |
| November 30, 2013 | 0.00 |
| August 31, 2013 | 0.00 |
| May 31, 2013 | 0.00 |
| February 28, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Filana Therapeutics, Inc. | 0.00 |
| CorMedix, Inc. | 0.315 |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Breakthrough Chemistry, Inc. | 0.2335 |
| BioStem Technologies, Inc. | 0.0443 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.885M |
| Total Liabilities (Quarterly) | 6.178M |
| Shareholders Equity (Quarterly) | -4.772M |